Table 2.
The anti-tumor effect of the combined treatment of IS and cisplatin in mice
| Mice | Group | Tumor weight (g) | Inhibition rate (%) | q value |
|---|---|---|---|---|
| C57BL/6 | Control | 1.9 ± 0.21 | / | / |
| IS | 1.51 ± 0.2 | 20.53 | / | |
| DDP | 1.28 ± 0.22 | 32.63 | / | |
| IS+DDP | 0.91 ± 0.16 | 52.11 | 1.12 | |
| BALB/c-nu | Control | 1.49 ± 0.13 | / | / |
| IS | 1.06 ± 0.18 | 28.86 | / | |
| DDP | 0.82 ± 0.23 | 44.97 | / | |
| IS+DDP | 0.49 ± 0.17 | 67.12 | 1.1 |
Data were presented with mean ± SD. n = 5 in each group.